Trials / Conditions / Inhalational Anthrax
Inhalational Anthrax
5 registered clinical trials studyying Inhalational Anthrax — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients NCT03569553 | Emergent BioSolutions | — |
| Completed | Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunt NCT01952444 | Elusys Therapeutics | Phase 1 |
| Completed | Intramuscular Dose-Escalation Study With ETI-204 in Adult Volunteers NCT01932437 | Elusys Therapeutics | Phase 1 |
| Completed | Safety, Tolerability and PK of Repeat Administration of Intravenous ETI-204 in Adult Volunteers NCT01932242 | Elusys Therapeutics | Phase 1 |
| Completed | Safety, Tolerability, and PK of a Single Intravenous Dose of ETI-204 in Adult Volunteers NCT01929226 | Elusys Therapeutics | Phase 1 |